Prof. David Andreu received his PhD from the University of
Barcelona in 1981 and served as associate professor at the University of
Barcelona (1986–2001). In 2002, he was appointed professor of Chemistry at
Pompeu Fabra University, Barcelona, where he leads the protein chemistry and
proteomics group, with a focus on peptide-based vaccines and pharmaceuticals.
He is the current president of the European Peptide Society and the
editor-in-chief of Drugs of the Future, and he has served on the board of the
Spanish Proteomics Society and the Spanish Society of Medicinal Chemistry.